Page last updated: 2024-09-04

lonafarnib and sch 44342

lonafarnib has been researched along with sch 44342 in 3 studies

Compound Research Comparison

Studies
(lonafarnib)
Trials
(lonafarnib)
Recent Studies (post-2010)
(lonafarnib)
Studies
(sch 44342)
Trials
(sch 44342)
Recent Studies (post-2010) (sch 44342)
6031200
22434901200

Protein Interaction Comparison

ProteinTaxonomylonafarnib (IC50)sch 44342 (IC50)
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)0.625
Protein farnesyltransferase subunit betaHomo sapiens (human)0.625
Protein farnesyltransferase subunit betaRattus norvegicus (Norway rat)0.25
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaRattus norvegicus (Norway rat)0.25

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afonso, A; Alvarez, CS; Bishop, WR; Connolly, M; Cooper, AB; del Rosario, J; Desai, J; Deskus, J; Ganguly, AK; Kelly, J; Kirschmeier, P; Liu, YT; Mallams, AK; Njoroge, FG; Patton, R; Pinto, P; Rane, DF; Remiszewski, S; Rossman, RR; Taveras, AG; Vibulbhan, B; Wang, J; Wang, L; Wolin, R; Wong, J1
Albanese, MM; Alvarez, CS; Cesarz, D; del Rosario, J; Deskus, J; Doll, RJ; Ganguly, AK; Girijavallabhan, VM; Le, HV; Mallams, AK; Njoroge, FG; Piwinski, JJ; Remiszewski, S; Rossman, RR; Strickland, CL; Taveras, AG; Vibulbhan, B; Weber, PC; Windsor, WT; Wu, Z1
Bell, IM1

Reviews

1 review(s) available for lonafarnib and sch 44342

ArticleYear
Inhibitors of farnesyltransferase: a rational approach to cancer chemotherapy?
    Journal of medicinal chemistry, 2004, Apr-08, Volume: 47, Issue:8

    Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Design; Farnesyltranstransferase; Genes, ras; Humans; Neoplasms

2004

Other Studies

2 other study(ies) available for lonafarnib and sch 44342

ArticleYear
(+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agent.
    Journal of medicinal chemistry, 1998, Nov-19, Volume: 41, Issue:24

    Topics: Alkyl and Aryl Transferases; Animals; Antineoplastic Agents; COS Cells; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Humans; Macaca fascicularis; Mice; Mice, Nude; Piperidines; Protein Prenylation; Pyridines; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured

1998
Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships.
    Journal of medicinal chemistry, 1999, Jun-17, Volume: 42, Issue:12

    Topics: Alkyl and Aryl Transferases; Antineoplastic Agents; Binding Sites; Calorimetry; Crystallography, X-Ray; Cyclic N-Oxides; Enzyme Inhibitors; Heterocyclic Compounds, 3-Ring; Hydrogen Bonding; Models, Molecular; Piperidines; Protein Prenylation; Pyridines; Thermodynamics

1999